US88025T1025 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 541.1M 22.92% | 683.2M 26.26% | 798.71M 16.91% | 919.95M 15.18% | ||||||||
EBITDA YoY % growth | -18.7M 27.52% | -42.1M -125.13% | -11.081M 73.68% | 174.17M 1,671.79% | N/A | N/A | ||||||
EBIT YoY % growth | -34.9M 4.12% | -64.3M -84.24% | -38.189M 40.61% | 158.17M 514.18% | N/A | N/A | ||||||
Operating Margin | -6.45% | -9.41% | -4.78% | 17.19% | N/A | N/A | ||||||
EPS YoY % growth | 0.34 100.00% | 0.38 11.76% | 0.81 113.16% | 1.10 35.95% |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 0.26 19.45% | ||||||||||
Revenue Q2Q % growth | 223.86M 14.80% | ||||||||||
EBITDA Q2Q % growth | 42.352M | ||||||||||
EBIT Q2Q % growth | 37.386M 449.40% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 0.25 127.27% | 0.18 | 0.07 | 37.86% |
Q4 2023 Q2Q % growth | 0.25 108.33% | 0.14 | 0.11 | 76.77% |
Q3 2023 Q2Q % growth | 0.23 53.33% | 0.19 | 0.04 | 22.77% |
Q2 2023 Q2Q % growth | 0.22 340.00% | 0.13 | 0.09 | 66.71% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 215.961M 14.39% | 217.85M | -1.889M | -0.87% |
Q4 2023 Q2Q % growth | 213.306M 15.55% | 210.6M | 2.706M | 1.28% |
Q3 2023 Q2Q % growth | 201.5M 15.21% | 202.36M | -860K | -0.42% |
Q2 2023 Q2Q % growth | 195M 18.69% | 194M | 1M | 0.52% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | 34.26% | 0% | 32.73% |
Revenue | 0% | -0.74% | 0% | -0.35% |